Holen Sie sich die Stockscreener-App
165.04
2.38%
3.843
Handel nachbörslich:
164.87
-0.1723
-0.10%
Schlusskurs vom Vortag:
$161.20
Offen:
$165.43
24-Stunden-Volumen:
448
Relative Volume:
0.22
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.65%
1M Leistung:
-0.93%
6M Leistung:
-0.27%
1J Leistung:
+42.17%
1-Tages-Spanne:
$164.87
$165.43
1-Wochen-Bereich:
$160.59
$169.85
52-Wochen-Spanne:
$82.50
$190.01
Tradr 2 X Long Innovation 100 Quarterly Etf Stock (QQQP) Company Profile
Firmenname
Tradr 2 X Long Innovation 100 Quarterly Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare QQQP vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QQQP
Tradr 2 X Long Innovation 100 Quarterly Etf
|
165.04 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
329.46 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
669.03 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
671.91 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
262.88 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
600.38 | 124.43B | 0 | 0 | 0 | 0.00 |
Tradr 2 X Long Innovation 100 Quarterly Etf Aktie (QQQP) Neueste Nachrichten
Osteoarthritis Clinical Trial Pipeline Expands as 100+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com
Multiple Myeloma Clinical Trial Pipeline Expands as 75+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com
Vonage Brings Network Innovation to Mobile World Congress 2026 - Barchart.com
Stock List: Research Stocks from Around the World - GuruFocus
Hepatic Tumor Clinical Trial Pipeline Expands as 75+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com
Danaher Announces Quarterly Dividend - Barchart.com
QQQP Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
QQQP Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Western Digital Is Selling Sandisk Stock. Should You? - Barchart.com
1 Nasdaq 100 Stock for Long-Term Investors and 2 That Underwhelm - Barchart.com
DuPont Announces Regular Quarterly Dividend on Common Stock - Barchart.com
Amkor Technology Declares Quarterly Dividend - Barchart.com
Workiva’s (NYSE:WK) Q4 CY2025 Sales Beat Estimates, Stock Soars - Barchart.com
AbbVie Declares Quarterly Dividend - Barchart.com
Ocular melanoma Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Delcath System, Aura Biosciences, Seagen, IDEAYA, Ascentage Pharma - Barchart.com
Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results Release - Barchart.com
Humana Board Declares Payment of Quarterly Dividend to Stockholders - Barchart.com
Eczema Pipeline 2026 Outlook: 100+ Clinical Assets and 3 Key Late-Stage Candidates to Watch, analyses DelveInsight - Barchart.com
Matthew Chapman – Windermere Real Estate Named #1 Real Estate Agent in Bellevue by CX Research Institute - Barchart.com
Coherent Corp. to Host a Technology Innovation Briefing on March 17, 2026 - Barchart.com
CAMTEK ANNOUNCES RECORD RESULTS FOR THE FOURTH QUARTER & FULL YEAR 2025 - Barchart.com
Hormel Foods Announces Preliminary First Quarter 2026 Results and Reaffirms Full-Year Adjusted Guidance - Barchart.com
Cathie Wood Adds 210K Shares to a Rising AI Bet With Upside of 102% - Barchart.com
West Announces Quarterly Dividend and Share Repurchase Program - Barchart.com
Webull to Release Fourth Quarter 2025 Results on March 4, 2026 - Barchart.com
Symbol Lookup - GuruFocus
Enpro Increases Quarterly Dividend - Barchart.com
ABNB Q4 Deep Dive: Product Innovation and Global Expansion Drive Momentum - Barchart.com
SPY, QQQP: Big ETF Outflows - Intellectia AI
Stocks Rise Before the Open on U.S. Economic Optimism, Earnings and Jobless Claims Data in Focus - Barchart.com
CarParts.com Sets Fourth Quarter 2025 Conference Call for Thursday, March 5, 2026 - Barchart.com
V2X Awarded $100M In National Security Contracts - Barchart.com
Radian Declares Regular Quarterly Dividend - Barchart.com
Coca-Cola demand rises in fourth quarter but shares slide on tepid outlook - Barchart.com
Ichthyosis Market: Rapid Increment Driven by Innovation – DelveInsight | Timber Pharma, Krystal Biotech, GSK, Timber Pharma, Janssen Scientific - Barchart.com
IgA Nephropathy Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Visterra, Chinook Therapeutics, Novartis, IgA proteases Selecta Biosciences - Barchart.com
Bladder Cancer Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Bristol-Myers Squibb Company, GlaxoSmithKline PLC., Johnson & Johnson, Janssen Pharma, F. Hoffmann-La Roche., Merck - Barchart.com
Vonage Wins Two Juniper Research Awards for Innovation in Network and Mobile Identity Solutions - Barchart.com
Advanced Energy Declares Quarterly Cash Dividend - Barchart.com
Diabetes Clinical Trial Pipeline Expands as 200+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com
Salesforce Announces Timing of its Fourth Quarter and Full Year Fiscal 2026 Results Conference Call - Barchart.com
Epique Realty Named 2026 HousingWire Tech100 Real Estate Winner - Barchart.com
CMG Q4 Deep Dive: Value Push, Menu Innovation, and Margins Under Pressure - Barchart.com
Franklin Resources, Inc. Announces Quarterly Dividend - Barchart.com
Cathie Wood Keeps Buying Joby Aviation Stock. Should You? - Barchart.com
7 Best Tech ETFs to Buy in 2026 | Investing - US News Money
Playground Play Equipment Innovation Sets New Benchmark for Safe, Engaging Spaces, Says Golden Times - Barchart.com
Starbucks feels the heat as more chains compete for US coffee drinkers - Barchart.com
Orbit Capital Announces Founder First Ecosystem Supporting 45 Companies - Barchart.com
Dr. Nitun Ahir Establishes New Academic Scholarship to Foster Innovation and Strategic Leadership in Modern Medicine - Barchart.com
Dr. Robert Corkern Award for Entrepreneurs Announces 2026 Application Cycle for Undergraduate Innovators - Barchart.com
Finanzdaten der Tradr 2 X Long Innovation 100 Quarterly Etf-Aktie (QQQP)
Es liegen keine Finanzdaten für Tradr 2 X Long Innovation 100 Quarterly Etf (QQQP) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.76%
Kapitalisierung:
|
Volumen (24h):